| Authors: |
Pujalte Martin M; Department of Medical Oncology, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France. Electronic address: marc.pujalte@yahoo.fr., Borchiellini D; Department of Medical Oncology, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France., Thamphya B; Research Departement, Epidemiology and Bioinformatics Unit, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France., Guillot A; Department of Medical Oncology, Lucien Neuwirth Cancer Institute, Saint Priest en Jarez, France., Paoli JB; Department of Radiotherapy, Hôpital privé de Clairval, Marseille, France., Besson D; Department of Medical Oncology, Centre Cario-HPCA, Plérin, France., Hilgers W; Department of Medical Oncology, Sainte Catherine Cancer Institute, Avignon Provence, France., Priou F; Department of Medical Oncology, CHD Vendée, La Roche sur Yon, France., El Kouri C; Department of Medical Oncology, Centre Catherine de Sienne, Nantes, France., Hoch B; Department of Medical Oncology, Centre Azuréen de Cancérologie, Mougins., Deville JL; Department of Medical Oncology, APHM - CHU Timone, Marseille, France., Schiappa R; Research Departement, Epidemiology and Bioinformatics Unit, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France., Cheli S; Clinical Research and Innovation Department, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France., Milano G; Oncopharmacology Unit, EA3836, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France., Tanti JF; Inserm U1065, C3M, Université Côte d'Azur, Nice, France., Bost F; Inserm U1065, C3M, Université Côte d'Azur, Nice, France. Electronic address: frederic.bost@unice.fr., Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France; Inserm U1065, C3M, Université Côte d'Azur, Nice, France. |
